Lista de obras - Konstantin Chegaev - Dominio Público Uruguay

(Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins

artículo científico publicado en 2009

A nitric oxide-donor furoxan moiety improves the efficacy of edaravone against early renal dysfunction and injury evoked by ischemia/reperfusion

artículo científico publicado en 2015

Aceclofenac–Galactose Conjugate: Design, Synthesis, Characterization, and Pharmacological and Toxicological Evaluations

artículo científico publicado en 2018

Amphiphilic NO-Donor Antioxidants

artículo científico publicado en 2007

Correction to "Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance"

artículo científico publicado en 2019

Design, Synthesis and Characterization of N-oxide-containing Heterocycles with In vivo Sterilizing Antitubercular Activity.

artículo científico publicado en 2017

Development of a new class of potential antiatherosclerosis agents: NO-donor antioxidants.

artículo científico publicado en 2004

Doxorubicin-antioxidant co-drugs

artículo científico publicado en 2013

Edaravone derivatives containing NO-donor functions

artículo científico publicado en 2009

Furazan and furoxan sulfonamides are strong α-carbonic anhydrase inhibitors and potential antiglaucoma agents

artículo científico publicado en 2014

Galactosylated Pro-Drug of Ursodeoxycholic Acid: Design, Synthesis, Characterization, and Pharmacological Effects in a Rat Model of Estrogen-Induced Cholestasis.

artículo científico publicado en 2017

Leishmanicidal activities of novel synthetic furoxan and benzofuroxan derivatives

artículo científico publicado en 2014

Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance

artículo científico publicado en 2017

Liposomal nitrooxy-doxorubicin: one step over caelyx in drug-resistant human cancer cells

artículo científico publicado en 2014

Mitochondrial-targeting nitrooxy-doxorubicin: a new approach to overcome drug resistance

artículo científico publicado en 2012

Multitarget drugs: Focus on the NO-donor hybrid drugs

NO release regulated by doxorubicin as the green light-harvesting antenna

scientific article published on 21 May 2020

NO-Donor COX-2 Inhibitors. New Nitrooxy-Substituted 1,5-Diarylimidazoles Endowed with COX-2 Inhibitory and Vasodilator Properties

scientific article published on 03 March 2007

NO-Donor Phenols: A New Class of Products Endowed with Antioxidant and Vasodilator Properties

scientific article published on 01 May 2006

NO-donor melatonin derivatives: synthesis and in vitro pharmacological characterization

artículo científico publicado en 2007

NO-donor thiacarbocyanines as multifunctional agents for Alzheimer's disease

artículo científico publicado en 2015

New Nitric Oxide or Hydrogen Sulfide Releasing Aspirins

artículo científico publicado en 2011

New Tetrahydroisoquinoline Derivatives Overcome Pgp Activity in Brain-Blood Barrier and Glioblastoma Multiforme in Vitro

scientific article published on 09 June 2018

New furoxan derivatives for the treatment of ocular hypertension

artículo científico publicado en 2016

New tetrahydroisoquinoline-based P-glycoprotein modulators: decoration of the biphenyl core gives selective ligands

scientific article published on 03 April 2018

Nitric oxide donor doxorubicins accumulate into Doxorubicin-resistant human colon cancer cells inducing cytotoxicity

artículo científico publicado en 2011

Novel antioxidant agents deriving from molecular combination of Vitamin C and NO-donor moieties

artículo científico publicado en 2008

Overcoming multidrug resistance by targeting mitochondria with NO-donating doxorubicins.

artículo científico publicado en 2016

Paracetamol-Galactose Conjugate: A Novel Prodrug for an Old Analgesic Drug

artículo científico publicado en 2019

Phenylsulfonylfuroxans as modulators of multidrug-resistance-associated protein-1 and P-glycoprotein

artículo científico publicado en 2010

Synthesis of some novel organic nitrates and comparative in vitro study of their vasodilator profile

artículo científico publicado en 2009

Synthesis physicochemical profile and PAMPA study of new NO-donor edaravone co-drugs

scientific article published on 08 December 2011

Synthesis, chiral HPLC resolution and configuration assignment of 1-phenylglyceryl trinitrate stereomers

artículo científico publicado en 2006

Unsymmetrically substituted furoxans. Part 19. Methyl and phenylfuroxansulfonic acids and related sulfonamides

gem-Dinitroalkyl Benzenes: A Novel Class of IOP-Lowering Agents for the Treatment of Ocular Hypertension.

artículo científico publicado en 2017

Lista de obras de Konstantin Chegaev

(Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins

A nitric oxide-donor furoxan moiety improves the efficacy of edaravone against early renal dysfunction and injury evoked by ischemia/reperfusion

Aceclofenac–Galactose Conjugate: Design, Synthesis, Characterization, and Pharmacological and Toxicological Evaluations

Amphiphilic NO-Donor Antioxidants

Correction to "Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance"

Design, Synthesis and Characterization of N-oxide-containing Heterocycles with In vivo Sterilizing Antitubercular Activity.

Development of a new class of potential antiatherosclerosis agents: NO-donor antioxidants.

Doxorubicin-antioxidant co-drugs

Edaravone derivatives containing NO-donor functions

Furazan and furoxan sulfonamides are strong α-carbonic anhydrase inhibitors and potential antiglaucoma agents

Galactosylated Pro-Drug of Ursodeoxycholic Acid: Design, Synthesis, Characterization, and Pharmacological Effects in a Rat Model of Estrogen-Induced Cholestasis.

Leishmanicidal activities of novel synthetic furoxan and benzofuroxan derivatives

Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance

Liposomal nitrooxy-doxorubicin: one step over caelyx in drug-resistant human cancer cells

Mitochondrial-targeting nitrooxy-doxorubicin: a new approach to overcome drug resistance

Multitarget drugs: Focus on the NO-donor hybrid drugs

NO release regulated by doxorubicin as the green light-harvesting antenna

NO-Donor COX-2 Inhibitors. New Nitrooxy-Substituted 1,5-Diarylimidazoles Endowed with COX-2 Inhibitory and Vasodilator Properties

NO-Donor Phenols: A New Class of Products Endowed with Antioxidant and Vasodilator Properties

NO-donor melatonin derivatives: synthesis and in vitro pharmacological characterization

NO-donor thiacarbocyanines as multifunctional agents for Alzheimer's disease

New Nitric Oxide or Hydrogen Sulfide Releasing Aspirins

New Tetrahydroisoquinoline Derivatives Overcome Pgp Activity in Brain-Blood Barrier and Glioblastoma Multiforme in Vitro

New furoxan derivatives for the treatment of ocular hypertension

New tetrahydroisoquinoline-based P-glycoprotein modulators: decoration of the biphenyl core gives selective ligands

Nitric oxide donor doxorubicins accumulate into Doxorubicin-resistant human colon cancer cells inducing cytotoxicity

Novel antioxidant agents deriving from molecular combination of Vitamin C and NO-donor moieties

Overcoming multidrug resistance by targeting mitochondria with NO-donating doxorubicins.

Paracetamol-Galactose Conjugate: A Novel Prodrug for an Old Analgesic Drug

Phenylsulfonylfuroxans as modulators of multidrug-resistance-associated protein-1 and P-glycoprotein

Synthesis of some novel organic nitrates and comparative in vitro study of their vasodilator profile

Synthesis physicochemical profile and PAMPA study of new NO-donor edaravone co-drugs

Synthesis, chiral HPLC resolution and configuration assignment of 1-phenylglyceryl trinitrate stereomers

Unsymmetrically substituted furoxans. Part 19. Methyl and phenylfuroxansulfonic acids and related sulfonamides

gem-Dinitroalkyl Benzenes: A Novel Class of IOP-Lowering Agents for the Treatment of Ocular Hypertension.